Concepedia

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity

Chunjun Li, Jing Li, Qiu-Mei Zhang, Lin Lv, Rui Chen, Chun-feng Lv, Pei Yu, De-min Yu

Cardiovascular Diabetology · 2012 · 63 citations · 18 references

DOIFull text

Open access

References

18

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

William C. Duckworth, Carlos Abraira, Thomas Moritz et al. · New England Journal of Medicine · 2008 · 4.7K citations · Full text

Obesity and Diabetes in the Developing World — A Growing Challenge

Parvez Hossain, Bisher Kawar, Meguid El Nahas · New England Journal of Medicine · 2007 · 2.2K citations · Full text

, , +17

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

John B. Buse, Julio Rosenstock, Giorgio Sesti et al. · The Lancet · 2009 · 1.5K citations

, , +6

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck, Anders Frid, Kjeld Hermansen et al. · Diabetes Care · 2008 · 1.1K citations · Full text

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

Alan J. Garber, Robert R. Henry, Robert E. Ratner et al. · The Lancet · 2008 · 1K citations

, , +7